\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ \ \(4\)\
\-\ vitals\\:\\ wnl\\,\\ normotensive\\,\\ gen\\:\\ normal\\ appearing\\ female\\ consistent\\ with\\ stated\\ age\\.\\ a\\&o\\,\\ no\\ aniridia\\ or\\ hemihypertrophy\\ seen\\.\\ several\\ small\\ caf\\Ã\\©\\ au\\ lait\\ spots\\ scattered\\ across\\ trunk\\ each\\ less\\ then\\ 2cm\\.\\ abdominal\\ exam\\ shows\\ mildly\\ distended\\ abdomen\\ with\\ bilateral\\ palpable\\ flank\\ masses\\.\\ gu\\ exam\\:\\ tanner\\ stage\\ 1\\.\\ remainder\\ of\\ exam\\ wnl\ \(0\)\
\-\ lab\\ work\\:\ \(0\)\
\-\ cbc\\:\\ wbc\\:\\ 6\\.8\\,\\ hgb\\:13\\ plt\\:378\\,000\ \(0\)\
\-\ u\\/a\\:\\ wnl\ \(0\)\
\-\ cmp\\:wnl\ \(0\)\
\-\ our\\ patient\\ was\\ diagnosed\\ with\\ stage\\ 5\\ wilms\\ tumor\\ as\\ her\\ disease\\ was\\ present\\ bilaterally\\.\\ \\ prior\\ to\\ her\\ several\\ kidney\\ surgeries\\ the\\ patient\\ underwent\\ several\\ rounds\\ of\\ chemotherapy\\ including\\ actinomycin\\ and\\ vincristine\\ in\\ hopes\\ of\\ shrinking\\ the\\ kidney\\ and\\ allowing\\ for\\ sparing\\ of\\ some\\ of\\ its\\ function\\.\\ \\ the\\ patient\\ then\\ underwent\\ l\\ radical\\ nephrectomy\\ with\\ r\\ partial\\ nephrectomy\\.\\ \\ she\\ is\\ followed\\ closely\\ with\\ hematology\\ and\\ oncology\\ as\\ well\\ as\\ urology\\.\\ \\ she\\ will\\ require\\ recurrent\\ ultrasounds\\ and\\ ct\\ scans\\ to\\ monitor\\ for\\ recurrence\\ of\\ disease\\.\\ \\ regular\\ follow\\ up\\ with\\ her\\ pcp\\ is\\ suggested\\ for\\ routine\\ physical\\ exams\\ and\\ evaluation\\ of\\ patients\\ current\\ symptoms\\.\\ \\ abnormalities\\ in\\ either\\ of\\ these\\ screening\\ measures\\ may\\ indicate\\ reoccurrence\\ may\\ indicate\\ reoccurrence\\.\\ patient\\ symptoms\\ should\\ be\\ followed\\ as\\ well\\ as\\ these\\ may\\ indicate\\ recurrence\\ of\\ disease\\.\ \(0\)\
\-\ 1\\)ct\\ of\\ chest\\,\\ abdomen\\,\\ and\\ pelvis\\ with\\ contrast\\,\\ \ \(0\)\
\-\ the\\ right\\ kidney\\ apparently\\ has\\ a\\ single\\ mass\\.\\ it\\ is\\ measured\\ at\\ 5\\ x\\ 5\\.7x\\ 5\\.6\\ cm\\.\\ the\\ remainder\\ of\\ the\\ right\\ kidney\\ appears\\ to\\ enhance\\ and\\ excrete\\ normally\\.\\ the\\ right\\ renal\\ collecting\\ system\\ does\\ not\\ appear\\ to\\ be\\ involved\\.\\ the\\ left\\ kidney\\ is\\ much\\ more\\ difficult\\ to\\ evaluate\\.\\ there\\ are\\ at\\ least\\ seven\\ left\\ renal\\ masses\\.\\ the\\ largest\\ mass\\ on\\ the\\ left\\ anterior\\ and\\ off\\ the\\ inferior\\ pole\\.\\ it\\ measures\\ 5\\.5\\ x\\ 4\\.9\\ x\\ 4\\.1\\ cm\\.\\ this\\ mass\\ is\\ the\\ most\\ heterogenous\\ and\\ may\\ be\\ more\\ vascular\\ than\\ the\\ remainder\\ of\\ the\\ masses\\.\\ a\\ second\\ mass\\ is\\ identified\\ superior\\ and\\ about\\ the\\ same\\ level\\ anteriorly\\ on\\ the\\ right\\ kidney\\.\\ this\\ measures\\ 3\\.3\\ x\\ 3\\.0\\ x\\ 2\\.4\\ cm\\.\\ on\\ the\\ ultrasound\\ i\\ believe\\ that\\ the\\ masses\\ were\\ multi\\-\\ lobulated\\,\\ but\\ i\\ believe\\ they\\ actually\\ are\\ separate\\ masses\\.\\ a\\ second\\ inferior\\ pole\\ mass\\ measures\\ 3\\.7\\ x\\ 4\\.3\\ x\\ 4\\.1\\ cm\\.\\ smaller\\ masses\\ are\\ identified\\ in\\ the\\ left\\ kidney\\,\\ more\\ posteriorly\\,\\ measuring\\ approximately\\ 12\\ x\\ 12\\ mm\\,\\ 11\\ x\\ 16\\ mm\\ and\\ 21\\ x\\ 18\\ mm\\.\\ i\\ see\\ no\\ evidence\\ of\\ free\\ fluid\\ in\\ the\\ pelvis\\.\\ there\\ is\\ no\\ definite\\ mesenteric\\ adenopathy\\.\\ the\\ bladder\ \(0\)\
\-\ is\\ unremarkable\\.\\ i\\ see\\ no\\ evidence\\ of\\ enlarged\\ inguinal\\ nodes\\.\\ there\\ is\\ shotty\\ inguinal\\ adenopathy\\ bilaterally\\.\ \(0\)\
\-\ 2\\)abdominal\\ ultrasound\\:\\ the\\ left\\ kidney\\ is\\ outside\\ two\\ standard\\ deviations\\ of\\ normal\\ in\\ size\\.\\ \\ it\\ measures\\ 5\\.7\\ cm\\ in\\ longest\\ dimension\\ with\\ 9\\ cm\\ being\\ upper\\ limits\\ of\\ normal\\ for\\ this\\ age\\.\\ \\ inferior\\ to\\ the\\ spleen\\ there\\ is\\ a\\ solid\\ appearing\\ mass\\ which\\ appears\\ to\\ adjoin\\ the\\ left\\ kidney\\.\\ this\\ mass\\ is\\ echogenic\\ in\\ nature\\ and\\ multi\\-lobulated\\.\\ it\\ measures\\ 8\\.4\\ x\\ 4\\.3\\ x\\ 7\\.1\\ cm\\.\\ inferior\\ to\\ the\\ mass\\ there\\ is\\ relatively\\ normal\\ appearing\\ left\\ kidney\\.\\ the\\ measurements\\ stated\\ for\\ the\\ left\\ kidney\\ include\\ only\\ the\\ normal\\ portion\\ of\\ the\\ kidney\\.\\ \\ images\\ of\\ the\\ right\\ kidney\\ also\\ demonstrate\\ a\\ solid\\ appearing\\ mass\\ off\\ the\\ superior\\ pole\\.\\ the\\ right\\ kidney\\ measures\\ 7\\.4\\ cm\\ in\\ longest\\ dimension\\ without\\ the\\ addition\\ of\\ the\\ mass\\.\\ the\\ mass\\ measures\\ 5\\.5\\ x\\ 3\\.1\\ x\\ 4\\.8\\ cm\\.\\ it\\ again\\ is\\ echogenic\\ and\\ solid\\ in\\ appearance\\ suggesting\\ a\\ solid\\ renal\\ tumor\\.\\ the\\ inferior\\ portion\\ of\\ the\\ right\\ kidney\\ is\\ more\\ normal\\ in\\ appearance\\,\\ without\\ evidence\\ of\\ hydronephrosis\\,\\ echogenic\\ focus\\ to\\ suggest\\ a\\ stone\\,\\ or\\ perinephric\\ fluid\\ collections\\.\ \(0\)\
\-\ nephroblastomatosis\\ with\\ bilateral\\ wilms\\ tumors\ \(0\)\
\-\ neuroblastoma\ \(81\)\
\-\ hydronephrosis\ \(122\)\
\-\ multicystic\\ dysplastic\\ kidney\ \(3\)\
\-\ multilocular\\ cystic\\ nephroma\ \(0\)\
\-\ renal\\ vein\\ thrombosis\ \(4\)\
\-\ pckd\ \(0\)\
\-\ congenital\\ mesoblastic\\ nephroma\ \(2\)\
\-\ adrenal\\ hemorrage\ \(0\)\
\-\ lymphoma\ \(373\)\
\-\ pt\\ is\\ a\\ 3\\ y\\.o\\ female\\ who\\ presented\\ to\\ pcp\\ with\\ distended\\ abdomen\\ and\\ mild\\ constipation\\ x\\ 2\\-3\\ weeks\\.\\ \\ denies\\ nausea\\,\\ vomiting\\,\\ fever\\,\\ chills\\.\\ \\ the\\ patient\\ denies\\ weight\\ loss\\,\\ night\\ sweats\\,\\ and\\ hematuria\\.\\ \\ no\\ significant\\ pmh\\.\\ \\ the\\ patient\\ was\\ then\\ sent\\ for\\ ultrasound\\,\\ which\\ showed\\ bilateral\\ enlargement\\ of\\ the\\ kidneys\\ with\\ solid\\ masses\\ in\\ both\\,\\ confirmed\\ by\\ ct\\.\\ she\\ was\\ referred\\ to\\ urology\\ for\\ further\\ evaluation\\.\ \(0\)\
\-\ path\\ report\\:\ \(0\)\
\-\ a\\.\\ specimen\\:\\ l\\ radical\\ nephrectomy\\:\ \(0\)\
\-\ microscopic\\ examination\\:\ \(0\)\
\-\ tumor\\ cells\\ in\\ the\\ yellow\\ area\\ resemble\\ those\\ of\\ the\\ previous\\ renal\\ biopsy\\.\\ a\\ triphasic\\ tumor\\ with\\ a\\ prominent\\ blastemal\\ component\\ is\\ present\\.\\ \\ in\\ the\\ adjacent\\ grey\\-white\\ to\\ brown\\ areas\\,\\ the\\ tumor\\ shows\\ more\\ prominent\\ epithelial\\ components\\ with\\ prominent\\ pleomorphism\\.\\ \\ the\\ stromal\\ component\\ in\\ both\\ areas\\ is\\ much\\ less\\ prominent\\ compared\\ to\\ the\\ previous\\ partial\\ right\\ nephrectomy\\.\\ \\ multifocal\\ perilobar\\ nephrogenic\\ rests\\ are\\ present\\ adjacent\\ to\\ the\\ tumor\\ and\\ elsewhere\\ in\\ the\\ upper\\ pole\\.\\ \\ the\\ largest\\ upper\\ pole\\ lesion\\ shows\\ additional\\ papillary\\ change\\.\\ \\ a\\ microscopic\\ foci\\ of\\ tumor\\ is\\ present\\ on\\ the\\ surface\\ of\\ this\\ lesion\\ and\\ is\\ interpreted\\ as\\ contamination\\.\\ \\ no\\ extra\\ capsular\\ tumor\\ is\\ appreciable\\ in\\ the\\ lower\\ pole\\ lesions\\.\\ \\ intracapsular\\ metastatic\\ tumor\\ is\\ seen\\ fairly\\ frequently\\ in\\ the\\ tumor\\ blocks\\ and\\ 3\\ of\\ 10\\ lymph\\ nodes\\ sections\\ form\\ the\\ hilar\\ region\\.\\ \\ focal\\ subcapsular\\ metastatic\\ tumor\\ is\\ also\\ present\\ in\\ these\\ affected\\ lymph\\ nodes\\.\\ \\ the\\ hilar\\ vascular\\ and\\ ureteral\\ surgical\\ margins\\ show\\ no\\ appreciable\\ tumor\\.\\ \\ \ \(0\)\
\-\ final\\ diagnosis\\:\\ \ \(0\)\
\-\ 1\\.wilms\\ tumor\\ s\\/p\\ chemotherapy\ \(0\)\
\-\ 2\\.nephroblastomatosis\\ s\\/p\\ chemotherapy\ \(0\)\
\-\ 3\\.intracapsular\\ metastatic\\ tumor\\,\\ kidney\ \(0\)\
\-\ 4\\.intracapsular\\ and\\ sub\\-capsular\\ metastatic\\ tumor\\,\\ hilar\\ lymph\\ nodes\\.\ \(0\)\
\-\ b\\.\\ specimen\\:\\ r\\ partial\\ nephrectomy\ \(0\)\
\-\ microscopic\\ evaluation\ \(1\)\
\-\ permanent\\ sections\\ show\\ renal\\ tissue\\,\\ a\\ thick\\ fibrous\\ capsule\\ and\\ adjacent\\ nephroblastoma\\ with\\ blastemal\\ areas\\ and\\ extensive\\ tubular\\ areas\\.\\ \\ abundant\\ lymphocytic\\ infiltrate\\ is\\ observed\\ in\\ this\\ area\\.\\ \\ inked\\ margins\\ show\\ capsular\\ surface\\ free\\ of\\ neoplasm\\.\\ medial\\ edge\\ of\\ kidney\\ section\\ shows\\ tubular\\ nephroblastoma\\ infiltrating\\ margins\\ of\\ excision\\ focally\\.\ \(0\)\
\-\ final\\ diagnosis\\:\ \(0\)\
\-\ 1\\)\\	wilms\\ tumor\\ with\\ favorable\\ histology\ \(0\)\
\-\ 2\\)\\	renal\\ medial\\ edge\\ with\\ focal\\ nephroblastoma\\ at\\ margin\\ of\\ excision\ \(0\)\
\-\ final\\ diagnosis\\:\\ bilateral\\ wilms\\ tumors\\ with\\ areas\\ of\\ nephroblastomatosis\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ kidney\\:\\ 0\\.05160657351514303\ \(0\)\
\-\ x\\:\\ 0\\.04027237621924967\ \(0\)\
\-\ tumor\\:\\ 0\\.030357825548355217\ \(0\)\
\-\ measures\\:\\ 0\\.027858766664776907\ \(0\)\
\-\ nephrectomy\\:\\ 0\\.023072507192449417\ \(0\)\
\-\ pole\\:\\ 0\\.022738494382942974\ \(0\)\
\-\ wilms\\:\\ 0\\.020149172949906046\ \(0\)\
\-\ cm\\:\\ 0\\.01964533815271702\ \(0\)\
\-\ \\:\\:\\ 0\\.019376139702697116\ \(0\)\
\-\ masses\\:\\ 0\\.01925728265330725\ \(0\)\
\-\ nephroblastoma\\:\\ 0\\.019245933949390462\ \(0\)\
\-\ renal\\:\\ 0\\.017116503663053798\ \(0\)\
\-\ wnl\\:\\ 0\\.01670362523856451\ \(0\)\
\-\ solid\\:\\ 0\\.016230222154792286\ \(0\)\
\-\ microscopic\\:\\ 0\\.015566350268514353\ \(0\)\
\-\ longest\\:\\ 0\\.015471183320774386\ \(0\)\
\-\ blastemal\\:\\ 0\\.015471183320774386\ \(0\)\
\-\ nodes\\:\\ 0\\.014703586157581857\ \(0\)\
\-\ appearing\\:\\ 0\\.014469480332005995\ \(0\)\
\-\ reoccurrence\\:\\ 0\\.01415090297685068\ \(0\)\
\-\ indicate\\:\\ 0\\.013843504315469648\ \(0\)\
\-\ inferior\\:\\ 0\\.01380626838742411\ \(0\)\
\-\ areas\\:\\ 0\\.013692129386886033\ \(0\)\
\-\ i\\:\\ 0\\.013456436934203847\ \(0\)\
\-\ prominent\\:\\ 0\\.013360955148820165\ \(0\)\
\-\ final\\:\\ 0\\.01317378801307295\ \(0\)\
\-\ is\\:\\ 0\\.012852360648793729\ \(0\)\
\-\ nephroblastomatosis\\:\\ 0\\.012830622632926976\ \(0\)\
\-\ mass\\:\\ 0\\.012450543882307818\ \(0\)\
\-\ hilar\\:\\ 0\\.012267799562621308\ \(0\)\
\-\ echogenic\\:\\ 0\\.012146200664281893\ \(0\)\
\-\ nephroma\\:\\ 0\\.012058308141292376\ \(0\)\
\-\ believe\\:\\ 0\\.011764687798764266\ \(0\)\
\-\ remainder\\:\\ 0\\.011508647660527007\ \(0\)\
\-\ capsular\\:\\ 0\\.011183008466285825\ \(0\)\
\-\ margins\\:\\ 0\\.01108869854524516\ \(0\)\
\-\ 5\\.5\\:\\ 0\\.01108530695316668\ \(0\)\
\-\ 4\\.1\\:\\ 0\\.01108530695316668\ \(0\)\
\-\ appreciable\\:\\ 0\\.010903763753539394\ \(0\)\
\-\ sections\\:\\ 0\\.01081909372959495\ \(0\)\
\-\ 4\\.3\\:\\ 0\\.01066027161733009\ \(0\)\
\-\ pcp\\:\\ 0\\.010312992461532082\ \(0\)\
\-\ radical\\:\\ 0\\.010190061945079565\ \(0\)\
\-\ more\\:\\ 0\\.01017703004434365\ \(0\)\
\-\ urology\\:\\ 0\\.010074586474953023\ \(0\)\
\-\ lymph\\:\\ 0\\.009855835454127562\ \(0\)\
\-\ specimen\\:\\ 0\\.009765026609242975\ \(0\)\
\-\ partial\\:\\ 0\\.009763873492710701\ \(0\)\
\-\ dimension\\:\\ 0\\.009339991273406385\ \(0\)\
\-\ largest\\:\\ 0\\.009229002876979765\ \(0\)\
\-\ present\\:\\ 0\\.009190517875865148\ \(0\)\
\-\ inguinal\\:\\ 0\\.009158448073779099\ \(0\)\
\-\ it\\:\\ 0\\.009146897069204843\ \(0\)\
\-\ edge\\:\\ 0\\.009124127110916855\ \(0\)\
\-\ mm\\:\\ 0\\.00897770044798573\ \(0\)\
\-\ shows\\:\\ 0\\.008949995046586204\ \(0\)\
\-\ stated\\:\\ 0\\.00886978160115586\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.008751273671831044\ \(0\)\
\-\ then\\:\\ 0\\.008688476795491685\ \(0\)\
\-\ caf\\Ã\\©\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ hgb\\:13\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ plt\\:378\\,000\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ 5\\.7x\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ multi\\-\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ adjoin\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ multi\\-lobulated\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ pckd\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ 1\\.wilms\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ 2\\.nephroblastomatosis\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ 3\\.intracapsular\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ 4\\.intracapsular\\:\\ 0\\.008395731832349046\ \(0\)\
\-\ hydronephrosis\\:\\ 0\\.008199350318951712\ \(0\)\
\-\ metastatic\\:\\ 0\\.008194702489966059\ \(0\)\
\-\ bilateral\\:\\ 0\\.007900258016435978\ \(0\)\
\-\ distended\\:\\ 0\\.007873118470175768\ \(0\)\
\-\ several\\:\\ 0\\.007848836673492536\ \(0\)\
\-\ excrete\\:\\ 0\\.007735591660387193\ \(0\)\
\-\ perilobar\\:\\ 0\\.007735591660387193\ \(0\)\
\-\ sub\\-capsular\\:\\ 0\\.007735591660387193\ \(0\)\
\-\ adjacent\\:\\ 0\\.007719532126097906\ \(0\)\
\-\ normal\\:\\ 0\\.007654928311994863\ \(0\)\
\-\ in\\:\\ 0\\.007625283212061755\ \(0\)\
\-\ tubular\\:\\ 0\\.007579498127647658\ \(0\)\
\-\ much\\:\\ 0\\.0075346781325806205\ \(0\)\
\-\ show\\:\\ 0\\.0074947312414046455\ \(0\)\
\-\ off\\:\\ 0\\.007434025787105612\ \(0\)\
\-\ component\\:\\ 0\\.007434025787105612\ \(0\)\
\-\ l\\:\\ 0\\.007420071425025473\ \(0\)\
\-\ r\\:\\ 0\\.0073924656968301075\ \(0\)\
\-\ as\\:\\ 0\\.007386157176537873\ \(0\)\
\-\ aniridia\\:\\ 0\\.007349434414569893\ \(0\)\
\-\ hemihypertrophy\\:\\ 0\\.007349434414569893\ \(0\)\
\-\ au\\:\\ 0\\.007349434414569893\ \(0\)\
\-\ lait\\:\\ 0\\.007349434414569893\ \(0\)\
\-\ actinomycin\\:\\ 0\\.007349434414569893\ \(0\)\
\-\ triphasic\\:\\ 0\\.007349434414569893\ \(0\)\
\-\ her\\:\\ 0\\.007341176167099816\ \(0\)\
\-\ left\\:\\ 0\\.0072846115754126835\ \(0\)\
\-\ adenopathy\\:\\ 0\\.00724739643784808\ \(0\)\
\-\ ultrasound\\:\\ 0\\.007243207385732295\ \(0\)\
\-\ abdomen\\:\\ 0\\.007232526465416275\ \(0\)\
\-\ surface\\:\\ 0\\.007184939632470955\ \(0\)\
\-\ may\\:\\ 0\\.007140298548183329\ \(0\)\
\-\ the\\:\\ 0\\.007109963213329327\ \(0\)\
\-\ recurrence\\:\\ 0\\.00710080397854117\ \(0\)\
\-\ evaluation\\:\\ 0\\.00709211084521945\ \(0\)\
\-\ shrinking\\:\\ 0\\.00707545148842534\ \(0\)\
\-\ hematology\\:\\ 0\\.00707545148842534\ \(0\)\
\-\ shotty\\:\\ 0\\.00707545148842534\ \(0\)\
\-\ pleomorphism\\:\\ 0\\.00707545148842534\ \(0\)\
\-\ contamination\\:\\ 0\\.00707545148842534\ \(0\)\
\-\ stage\\:\\ 0\\.006942922721768279\ \(0\)\
\-\ right\\:\\ 0\\.006869574926555556\ \(0\)\
\-\ denies\\:\\ 0\\.0068686328973810995\ \(0\)\
\-\ 6\\.8\\:\\ 0\\.006862933820507046\ \(0\)\
\-\ u\\/a\\:\\ 0\\.006862933820507046\ \(0\)\
\-\ hemorrage\\:\\ 0\\.006862933820507046\ \(0\)\
\-\ inked\\:\\ 0\\.006862933820507046\ \(0\)\
\-\ she\\:\\ 0\\.0068536746898690635\ \(0\)\
\-\ s\\/p\\:\\ 0\\.0068274472516417365\ \(0\)\
\-\ free\\:\\ 0\\.006699430585558975\ \(0\)\
\-\ rounds\\:\\ 0\\.006689294242608041\ \(0\)\
\-\ 5\\.6\\:\\ 0\\.006689294242608041\ \(0\)\
\-\ excision\\:\\ 0\\.006680477574410083\ \(0\)\
\-\ 12\\:\\ 0\\.006661711295471013\ \(0\)\
\-\ 7\\.1\\:\\ 0\\.006542484071343986\ \(0\)\
\-\ grey\\-white\\:\\ 0\\.006542484071343986\ \(0\)\
\-\ \\,\\:\\ 0\\.006445477750411604\ \(0\)\
\-\ deviations\\:\\ 0\\.006415311316463488\ \(0\)\
\-\ 5\\.7\\:\\ 0\\.006415311316463488\ \(0\)\
\-\ mesoblastic\\:\\ 0\\.006415311316463488\ \(0\)\
\-\ nephrogenic\\:\\ 0\\.006415311316463488\ \(0\)\
\-\ evidence\\:\\ 0\\.006401264523905365\ \(0\)\
\-\ these\\:\\ 0\\.0063538419770224\ \(0\)\
\-\ previous\\:\\ 0\\.006320667045091993\ \(0\)\
\-\ hopes\\:\\ 0\\.006303136996790741\ \(0\)\
\-\ resemble\\:\\ 0\\.006303136996790741\ \(0\)\
\-\ second\\:\\ 0\\.006251674162359958\ \(0\)\
\-\ 4\\.9\\:\\ 0\\.006202793648545193\ \(0\)\
\-\ 7\\.4\\:\\ 0\\.006202793648545193\ \(0\)\
\-\ intracapsular\\:\\ 0\\.006202793648545193\ \(0\)\
\-\ blocks\\:\\ 0\\.006202793648545193\ \(0\)\
\-\ abundant\\:\\ 0\\.006202793648545193\ \(0\)\
\-\ tumors\\:\\ 0\\.006113745443181906\ \(0\)\
\-\ appears\\:\\ 0\\.006058531087232854\ \(0\)\
\-\ there\\:\\ 0\\.006055788364118994\ \(0\)\
\-\ tanner\\:\\ 0\\.006029154070646188\ \(0\)\
\-\ rests\\:\\ 0\\.006029154070646188\ \(0\)\
\-\ normotensive\\:\\ 0\\.005952922920480916\ \(0\)\
\-\ 8\\.4\\:\\ 0\\.005952922920480916\ \(0\)\
\-\ 4\\.8\\:\\ 0\\.005952922920480916\ \(0\)\
\-\ pelvis\\:\\ 0\\.005914459822079293\ \(0\)\
\-\ portion\\:\\ 0\\.005895631709255403\ \(0\)\
\-\ upper\\:\\ 0\\.0058916585867677665\ \(0\)\
\-\ ultrasounds\\:\\ 0\\.005882343899382133\ \(0\)\
\-\ identified\\:\\ 0\\.005816127697497755\ \(0\)\
\-\ 3\\.7\\:\\ 0\\.005755171144501635\ \(0\)\
\-\ multilocular\\:\\ 0\\.005755171144501635\ \(0\)\
\-\ no\\:\\ 0\\.005736294338025347\ \(0\)\
\-\ spots\\:\\ 0\\.005697433409438364\ \(0\)\
\-\ 3\\.3\\:\\ 0\\.005697433409438364\ \(0\)\
\-\ subcapsular\\:\\ 0\\.005697433409438364\ \(0\)\
\-\ to\\:\\ 0\\.005694241445906484\ \(0\)\
\-\ diagnosis\\:\\ 0\\.005606340945086914\ \(0\)\
\-\ multicystic\\:\\ 0\\.005591504233142913\ \(0\)\
\-\ elsewhere\\:\\ 0\\.005591504233142913\ \(0\)\
\-\ underwent\\:\\ 0\\.0055851353056727985\ \(0\)\
\-\ less\\:\\ 0\\.0055122666749003475\ \(0\)\
\-\ vincristine\\:\\ 0\\.0054961866535648335\ \(0\)\
\-\ 3\\.1\\:\\ 0\\.0054961866535648335\ \(0\)\
\-\ this\\:\\ 0\\.0054922126475093315\ \(0\)\
\-\ followed\\:\\ 0\\.0054569064216738504\ \(0\)\
\-\ focally\\:\\ 0\\.005451881876769697\ \(0\)\
\-\ measurements\\:\\ 0\\.005409546864797475\ \(0\)\
\-\ brown\\:\\ 0\\.005369013898684335\ \(0\)\
\-\ exam\\:\\ 0\\.005363525542712966\ \(0\)\
\-\ bilaterally\\:\\ 0\\.005346105216236006\ \(0\)\
\-\ vascular\\:\\ 0\\.005336768129378469\ \(0\)\
\-\ gu\\:\\ 0\\.005330135808665045\ \(0\)\
\-\ apparently\\:\\ 0\\.005330135808665045\ \(0\)\
\-\ favorable\\:\\ 0\\.005292782748519063\ \(0\)\
\-\ 2cm\\:\\ 0\\.00525683957901159\ \(0\)\
\-\ cmp\\:\\ 0\\.00525683957901159\ \(0\)\
\-\ allowing\\:\\ 0\\.00525683957901159\ \(0\)\
\-\ yellow\\:\\ 0\\.00525683957901159\ \(0\)\
\-\ permanent\\:\\ 0\\.00522220372742028\ \(0\)\
\-\ medial\\:\\ 0\\.005206284787790575\ \(0\)\
\-\ superior\\:\\ 0\\.005197607042007984\ \(0\)\
\-\ oncology\\:\\ 0\\.005188783422838118\ \(0\)\
\-\ lymphocytic\\:\\ 0\\.005188783422838118\ \(0\)\
\-\ perinephric\\:\\ 0\\.005156496230766041\ \(0\)\
\-\ path\\:\\ 0\\.005156496230766041\ \(0\)\
\-\ area\\:\\ 0\\.005146354750731937\ \(0\)\
\-\ trunk\\:\\ 0\\.005125267828077478\ \(0\)\
\-\ dysplastic\\:\\ 0\\.005125267828077478\ \(0\)\
\-\ interpreted\\:\\ 0\\.005125267828077478\ \(0\)\
\-\ seven\\:\\ 0\\.005095030972539783\ \(0\)\
\-\ extra\\:\\ 0\\.005095030972539783\ \(0\)\
\-\ 2\\.4\\:\\ 0\\.005065724630952398\ \(0\)\
\-\ stromal\\:\\ 0\\.005065724630952398\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.0050372932374765115\ \(0\)\
\-\ actually\\:\\ 0\\.005009686059501985\ \(0\)\
\-\ constipation\\:\\ 0\\.005009686059501985\ \(0\)\
\-\ o\\:\\ 0\\.004956762391735498\ \(0\)\
\-\ epithelial\\:\\ 0\\.004956762391735498\ \(0\)\
\-\ age\\:\\ 0\\.004954114905798679\ \(0\)\
\-\ a\\:\\ 0\\.004910283260611254\ \(0\)\
\-\ closely\\:\\ 0\\.004906625502701763\ \(0\)\
\-\ patient\\:\\ 0\\.004894811033807931\ \(0\)\
\-\ for\\:\\ 0\\.004860720990951434\ \(0\)\
\-\ see\\:\\ 0\\.004857556592816739\ \(0\)\
\-\ surgeries\\:\\ 0\\.004836046481602981\ \(0\)\
\-\ sparing\\:\\ 0\\.004836046481602981\ \(0\)\
\-\ b\\.\\:\\ 0\\.004836046481602981\ \(0\)\
\-\ infiltrate\\:\\ 0\\.004836046481602981\ \(0\)\
\-\ histology\\:\\ 0\\.004836046481602981\ \(0\)\
\-\ fairly\\:\\ 0\\.004770338984948741\ \(0\)\
\-\ ureteral\\:\\ 0\\.004770338984948741\ \(0\)\
\-\ 5\\:\\ 0\\.004762210328465073\ \(0\)\
\-\ appearance\\:\\ 0\\.004655060146161222\ \(0\)\
\-\ focal\\:\\ 0\\.004648559245977908\ \(0\)\
\-\ monitor\\:\\ 0\\.00463264257655721\ \(0\)\
\-\ sweats\\:\\ 0\\.00463264257655721\ \(0\)\
\-\ fluid\\:\\ 0\\.0046259792468644825\ \(0\)\
\-\ exams\\:\\ 0\\.004596699407049737\ \(0\)\
\-\ a\\.\\:\\ 0\\.004562063555458427\ \(0\)\
\-\ separate\\:\\ 0\\.004512362838153122\ \(0\)\
\-\ gen\\:\\ 0\\.004480613866469702\ \(0\)\
\-\ are\\:\\ 0\\.004437614752493721\ \(0\)\
\-\ measured\\:\\ 0\\.004420124908638915\ \(0\)\
\-\ infiltrating\\:\\ 0\\.004420124908638915\ \(0\)\
\-\ definite\\:\\ 0\\.004405584458990545\ \(0\)\
\-\ capsule\\:\\ 0\\.004405584458990545\ \(0\)\
\-\ 2\\-3\\:\\ 0\\.004391262671024317\ \(0\)\
\-\ spleen\\:\\ 0\\.004377153065514659\ \(0\)\
\-\ collections\\:\\ 0\\.004377153065514659\ \(0\)\
\-\ multifocal\\:\\ 0\\.004377153065514659\ \(0\)\
\-\ section\\:\\ 0\\.004363249447018322\ \(0\)\
\-\ across\\:\\ 0\\.004349545887540132\ \(0\)\
\-\ thick\\:\\ 0\\.004271223889219207\ \(0\)\
\-\ each\\:\\ 0\\.004210542161232437\ \(0\)\
\-\ heterogenous\\:\\ 0\\.004175906309641128\ \(0\)\
\-\ standard\\:\\ 0\\.004164635397596364\ \(0\)\
\-\ both\\:\\ 0\\.0041565714108307075\ \(0\)\
\-\ collecting\\:\\ 0\\.004153496312107609\ \(0\)\
\-\ suggested\\:\\ 0\\.004142486005058966\ \(0\)\
\-\ sent\\:\\ 0\\.004142486005058966\ \(0\)\
\-\ papillary\\:\\ 0\\.004131601532845992\ \(0\)\
\-\ adrenal\\:\\ 0\\.00412084005165177\ \(0\)\
\-\ lobulated\\:\\ 0\\.00408926652087377\ \(0\)\
\-\ least\\:\\ 0\\.004078970410298326\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.004068784420663328\ \(0\)\
\-\ chills\\:\\ 0\\.004068784420663328\ \(0\)\
\-\ abdominal\\:\\ 0\\.004068417596423077\ \(0\)\
\-\ symptoms\\:\\ 0\\.0040564904321869315\ \(0\)\
\-\ stone\\:\\ 0\\.00404873355476063\ \(0\)\
\-\ pmh\\:\\ 0\\.00404873355476063\ \(0\)\
\-\ normally\\:\\ 0\\.00400985546474134\ \(0\)\
\-\ anteriorly\\:\\ 0\\.003990995819697358\ \(0\)\
\-\ components\\:\\ 0\\.003990995819697358\ \(0\)\
\-\ disease\\:\\ 0\\.003990678689187726\ \(0\)\
\-\ lab\\:\\ 0\\.0039817042245112975\ \(0\)\
\-\ suggesting\\:\\ 0\\.00395436126652803\ \(0\)\
\-\ night\\:\\ 0\\.00395436126652803\ \(0\)\
\-\ smaller\\:\\ 0\\.00394541865667104\ \(0\)\
\-\ enhance\\:\\ 0\\.003936559235087884\ \(0\)\
\-\ again\\:\\ 0\\.003910464973956347\ \(0\)\
\-\ observed\\:\\ 0\\.0039019233834965746\ \(0\)\
\-\ vitals\\:\\ 0\\.0038934577192896737\ \(0\)\
\-\ 1\\:\\ 0\\.003873002605637537\ \(0\)\
\-\ our\\:\\ 0\\.0038685030789144133\ \(0\)\
\-\ hematuria\\:\\ 0\\.0038603280849226116\ \(0\)\
\-\ nature\\:\\ 0\\.00385222266619127\ \(0\)\
\-\ posteriorly\\:\\ 0\\.0038441856484333035\ \(0\)\
\-\ without\\:\\ 0\\.0038324060311584005\ \(0\)\
\-\ flank\\:\\ 0\\.0038283122651140544\ \(0\)\
\-\ margin\\:\\ 0\\.0038283122651140544\ \(0\)\
\-\ work\\:\\ 0\\.0038126991129467432\ \(0\)\
\-\ current\\:\\ 0\\.0038126991129467432\ \(0\)\
\-\ 3\\:\\ 0\\.003811381955631504\ \(0\)\
\-\ form\\:\\ 0\\.0038049874841537728\ \(0\)\
\-\ scattered\\:\\ 0\\.003789749063823829\ \(0\)\
\-\ scans\\:\\ 0\\.003789749063823829\ \(0\)\
\-\ and\\:\\ 0\\.0037716172629607674\ \(0\)\
\-\ be\\:\\ 0\\.0037650192095540834\ \(0\)\
\-\ was\\:\\ 0\\.0037648667512902353\ \(0\)\
\-\ regular\\:\\ 0\\.0037526867626336636\ \(0\)\
\-\ mesenteric\\:\\ 0\\.0037526867626336636\ \(0\)\
\-\ kidneys\\:\\ 0\\.0037454442870286926\ \(0\)\
\-\ require\\:\\ 0\\.003724041567169589\ \(0\)\
\-\ 11\\:\\ 0\\.003724041567169589\ \(0\)\
\-\ those\\:\\ 0\\.0037031092750564702\ \(0\)\
\-\ 16\\:\\ 0\\.0036826271748460287\ \(0\)\
\-\ 21\\:\\ 0\\.0036826271748460287\ \(0\)\
\-\ well\\:\\ 0\\.0036820589580355257\ \(0\)\
\-\ pe\\:\\ 0\\.003655985410996118\ \(0\)\
\-\ focus\\:\\ 0\\.003655985410996118\ \(0\)\
\-\ report\\:\\ 0\\.003642938892559773\ \(0\)\
\-\ cbc\\:\\ 0\\.0036364820478117935\ \(0\)\
\-\ difficult\\:\\ 0\\.003562232960697782\ \(0\)\
\-\ either\\:\\ 0\\.0035445411649140343\ \(0\)\
\-\ 18\\:\\ 0\\.0035329266191103975\ \(0\)\
\-\ frequently\\:\\ 0\\.003527172033914243\ \(0\)\
\-\ affected\\:\\ 0\\.0035214520109997554\ \(0\)\
\-\ 2\\:\\ 0\\.0035049609457343737\ \(0\)\
\-\ thrombosis\\:\\ 0\\.0034933561401457574\ \(0\)\
\-\ foci\\:\\ 0\\.0034933561401457574\ \(0\)\
\-\ relatively\\:\\ 0\\.0034823458330971134\ \(0\)\
\-\ screening\\:\\ 0\\.0034714613608841393\ \(0\)\
\-\ mildly\\:\\ 0\\.0034660654203739704\ \(0\)\
\-\ suggest\\:\\ 0\\.0034660654203739704\ \(0\)\
\-\ function\\:\\ 0\\.003450058641025036\ \(0\)\
\-\ addition\\:\\ 0\\.003450058641025036\ \(0\)\
\-\ compared\\:\\ 0\\.0034447822787625456\ \(0\)\
\-\ of\\:\\ 0\\.0034396360235596584\ \(0\)\
\-\ recurrent\\:\\ 0\\.0034343164486905498\ \(0\)\
\-\ ct\\:\\ 0\\.0034151532954058367\ \(0\)\
\-\ involved\\:\\ 0\\.0034137236258208682\ \(0\)\
\-\ outside\\:\\ 0\\.0034137236258208682\ \(0\)\
\-\ 9\\:\\ 0\\.0033641092335509617\ \(0\)\
\-\ same\\:\\ 0\\.0033544891421352437\ \(0\)\
\-\ limits\\:\\ 0\\.0033544891421352437\ \(0\)\
\-\ female\\:\\ 0\\.0033462100408530164\ \(0\)\
\-\ appear\\:\\ 0\\.0033308556477355065\ \(0\)\
\-\ lesion\\:\\ 0\\.0033153432876199137\ \(0\)\
\-\ at\\:\\ 0\\.0033078947223760943\ \(0\)\
\-\ bladder\\:\\ 0\\.0033032484697609805\ \(0\)\
\-\ single\\:\\ 0\\.0032987240861813635\ \(0\)\
\-\ evaluate\\:\\ 0\\.0032897392935781647\ \(0\)\
\-\ fibrous\\:\\ 0\\.0032897392935781647\ \(0\)\
\-\ nausea\\:\\ 0\\.0032764190631260313\ \(0\)\
\-\ routine\\:\\ 0\\.0032632825658571404\ \(0\)\
\-\ cells\\:\\ 0\\.0032632825658571404\ \(0\)\
\-\ additional\\:\\ 0\\.0032632825658571404\ \(0\)\
\-\ measuring\\:\\ 0\\.0032546244975702335\ \(0\)\
\-\ extensive\\:\\ 0\\.0032546244975702335\ \(0\)\
\-\ enlargement\\:\\ 0\\.0032291127680810433\ \(0\)\
\-\ seen\\:\\ 0\\.0032164335525098862\ \(0\)\
\-\ also\\:\\ 0\\.0032087992260383833\ \(0\)\
\-\ system\\:\\ 0\\.00320426663847695\ \(0\)\
\-\ change\\:\\ 0\\.0031721157052150887\ \(0\)\
\-\ about\\:\\ 0\\.0031371976248611923\ \(0\)\
\-\ vomiting\\:\\ 0\\.0031071988943284575\ \(0\)\
\-\ its\\:\\ 0\\.003070982327100611\ \(0\)\
\-\ referred\\:\\ 0\\.003070982327100611\ \(0\)\
\-\ confirmed\\:\\ 0\\.0030603805743683785\ \(0\)\
\-\ which\\:\\ 0\\.0030383706423667595\ \(0\)\
\-\ pt\\:\\ 0\\.0030258702425073835\ \(0\)\
\-\ diagnosed\\:\\ 0\\.0029925668159952435\ \(0\)\
\-\ abnormalities\\:\\ 0\\.002989299639712587\ \(0\)\
\-\ congenital\\:\\ 0\\.0029763418758499407\ \(0\)\
\-\ wbc\\:\\ 0\\.0029667379529293445\ \(0\)\
\-\ vein\\:\\ 0\\.002944698401918207\ \(0\)\
\-\ including\\:\\ 0\\.0029384939438027845\ \(0\)\
\-\ they\\:\\ 0\\.002932329644273625\ \(0\)\
\-\ weight\\:\\ 0\\.002917091223943681\ \(0\)\
\-\ biopsy\\:\\ 0\\.002887326896796915\ \(0\)\
\-\ palpable\\:\\ 0\\.0028844009929521815\ \(0\)\
\-\ \\&\\:\\ 0\\.0028584646591823157\ \(0\)\
\-\ being\\:\\ 0\\.002835988549333865\ \(0\)\
\-\ does\\:\\ 0\\.002776781971794292\ \(0\)\
\-\ enlarged\\:\\ 0\\.002776781971794292\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0027715776913446936\ \(0\)\
\-\ on\\:\\ 0\\.0027576800471063928\ \(0\)\
\-\ fever\\:\\ 0\\.0027535834538590155\ \(0\)\
\-\ 10\\:\\ 0\\.0027434516460446766\ \(0\)\
\-\ size\\:\\ 0\\.0027284532108369252\ \(0\)\
\-\ \\)\\:\\ 0\\.002718238827098305\ \(0\)\
\-\ unremarkable\\:\\ 0\\.002694348970173391\ \(0\)\
\-\ showed\\:\\ 0\\.0026683840646892346\ \(0\)\
\-\ should\\:\\ 0\\.002594484325608381\ \(0\)\
\-\ further\\:\\ 0\\.0025880420398097697\ \(0\)\
\-\ follow\\:\\ 0\\.002585904258996604\ \(0\)\
\-\ will\\:\\ 0\\.002546172398456326\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0025420849202834293\ \(0\)\
\-\ examination\\:\\ 0\\.002529926700451967\ \(0\)\
\-\ approximately\\:\\ 0\\.0025179217395767456\ \(0\)\
\-\ some\\:\\ 0\\.0024713602417778657\ \(0\)\
\-\ only\\:\\ 0\\.002447058722366605\ \(0\)\
\-\ loss\\:\\ 0\\.0023623468309223235\ \(0\)\
\-\ y\\.o\\:\\ 0\\.0023489327929397145\ \(0\)\
\-\ cystic\\:\\ 0\\.0023472692450016747\ \(0\)\
\-\ level\\:\\ 0\\.002345608597758983\ \(0\)\
\-\ two\\:\\ 0\\.0023307916548723864\ \(0\)\
\-\ lymphoma\\:\\ 0\\.0023259034613233196\ \(0\)\
\-\ weeks\\:\\ 0\\.0023097883399058558\ \(0\)\
\-\ region\\:\\ 0\\.002298667835466012\ \(0\)\
\-\ include\\:\\ 0\\.0022830033219336065\ \(0\)\
\-\ presented\\:\\ 0\\.002218435842878485\ \(0\)\
\-\ \\.\\:\\ 0\\.002197590329835722\ \(0\)\
\-\ up\\:\\ 0\\.0021884258581468794\ \(0\)\
\-\ significant\\:\\ 0\\.0021884258581468794\ \(0\)\
\-\ lesions\\:\\ 0\\.0021786290536609026\ \(0\)\
\-\ mild\\:\\ 0\\.002143098527553464\ \(0\)\
\-\ than\\:\\ 0\\.0021324274808745465\ \(0\)\
\-\ who\\:\\ 0\\.0021218746753730497\ \(0\)\
\-\ patients\\:\\ 0\\.002106261523205739\ \(0\)\
\-\ anterior\\:\\ 0\\.0020959931654883214\ \(0\)\
\-\ prior\\:\\ 0\\.0020896312116212984\ \(0\)\
\-\ physical\\:\\ 0\\.001996671685315465\ \(0\)\
\-\ consistent\\:\\ 0\\.001995522160791622\ \(0\)\
\-\ chest\\:\\ 0\\.001947360952435732\ \(0\)\
\-\ tissue\\:\\ 0\\.0019289725604310416\ \(0\)\
\-\ or\\:\\ 0\\.0019076623789784906\ \(0\)\
\-\ with\\:\\ 0\\.0018943533271696433\ \(0\)\
\-\ most\\:\\ 0\\.0018788906111695963\ \(0\)\
\-\ small\\:\\ 0\\.001874833604172494\ \(0\)\
\-\ demonstrate\\:\\ 0\\.0018728115631743245\ \(0\)\
\-\ were\\:\\ 0\\.0018478917492284965\ \(0\)\
\-\ lower\\:\\ 0\\.0018303448279655835\ \(0\)\
\-\ contrast\\:\\ 0\\.0018216911302932433\ \(0\)\
\-\ but\\:\\ 0\\.00173571742955575\ \(0\)\
\-\ surgical\\:\\ 0\\.0017106874002394796\ \(0\)\
\-\ images\\:\\ 0\\.0015612037066184325\ \(0\)\
\-\ has\\:\\ 0\\.0015282856861850267\ \(0\)\
\-\ that\\:\\ 0\\.0014056959319607841\ \(0\)\
\-\ by\\:\\ 0\\.0013551151459474998\ \(0\)\
\-\ not\\:\\ 0\\.0011760177826113671\ \(0\)\
